Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	TAP complex binding	HLA-A HLA-B	3.70e-04	9	65	2	GO:0062061
GeneOntologyMolecularFunction	CD8 receptor binding	HLA-A HLA-B	3.70e-04	9	65	2	GO:0042610
GeneOntologyMolecularFunction	TAP1 binding	HLA-A HLA-B	4.62e-04	10	65	2	GO:0046978
GeneOntologyMolecularFunction	TAP2 binding	HLA-A HLA-B	4.62e-04	10	65	2	GO:0046979
GeneOntologyMolecularFunction	TAP binding	HLA-A HLA-B	4.62e-04	10	65	2	GO:0046977
GeneOntologyMolecularFunction	beta-2-microglobulin binding	HLA-A HLA-B	6.74e-04	12	65	2	GO:0030881
GeneOntologyBiologicalProcess	neuron development	EPOR OTX2 HLA-A TIAM1 HLA-B IFT88 GIT1 MYCBP2 LZTS1 P3H1 CNTN5 PBX1 EPB41L3 ADARB1 VPS13B	2.57e-05	1463	63	15	GO:0048666
GeneOntologyBiologicalProcess	neuron projection development	EPOR OTX2 HLA-A TIAM1 HLA-B IFT88 GIT1 MYCBP2 LZTS1 P3H1 CNTN5 EPB41L3 ADARB1 VPS13B	2.59e-05	1285	63	14	GO:0031175
GeneOntologyCellularComponent	keratohyalin granule	FLG HRNR FLG2	2.60e-07	5	63	3	GO:0036457
GeneOntologyCellularComponent	cis-Golgi network membrane	HLA-A HLA-B VPS13B	1.72e-05	17	63	3	GO:0033106
GeneOntologyCellularComponent	MHC class Ib protein complex	HLA-A HLA-B	1.86e-04	7	63	2	GO:0032398
GeneOntologyCellularComponent	MHC class I protein complex	HLA-A HLA-B	3.96e-04	10	63	2	GO:0042612
GeneOntologyCellularComponent	postsynaptic density	TIAM1 GIT1 LZTS1 PSD3 EPB41L3 HNRNPH1 HNRNPH2	4.05e-04	451	63	7	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	TIAM1 GIT1 LZTS1 PSD3 EPB41L3 HNRNPH1 HNRNPH2	5.66e-04	477	63	7	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	TIAM1 GIT1 LZTS1 PSD3 EPB41L3 HNRNPH1 HNRNPH2	7.74e-04	503	63	7	GO:0099572
GeneOntologyCellularComponent	MHC class I peptide loading complex	HLA-A HLA-B	7.95e-04	14	63	2	GO:0042824
GeneOntologyCellularComponent	9+2 non-motile cilium	TIAM1 IFT88	7.95e-04	14	63	2	GO:0097732
GeneOntologyCellularComponent	kinocilium	TIAM1 IFT88	7.95e-04	14	63	2	GO:0060091
GeneOntologyCellularComponent	neuron to neuron synapse	TIAM1 GIT1 LZTS1 PSD3 EPB41L3 HNRNPH1 HNRNPH2	9.72e-04	523	63	7	GO:0098984
GeneOntologyCellularComponent	cornified envelope	FLG HRNR FLG2	1.19e-03	69	63	3	GO:0001533
GeneOntologyCellularComponent	stereocilium bundle	TIAM1 IFT88 MYO15A	1.75e-03	79	63	3	GO:0032421
GeneOntologyCellularComponent	cis-Golgi network	HLA-A HLA-B VPS13B	2.16e-03	85	63	3	GO:0005801
GeneOntologyCellularComponent	Golgi medial cisterna	HLA-A HLA-B	2.17e-03	23	63	2	GO:0005797
GeneOntologyCellularComponent	azurophil granule lumen	MAN2B1 AGA HRNR	2.62e-03	91	63	3	GO:0035578
GeneOntologyCellularComponent	MHC protein complex	HLA-A HLA-B	2.77e-03	26	63	2	GO:0042611
GeneOntologyCellularComponent	postsynapse	TIAM1 GIT1 LZTS1 PSD3 EPB41L3 CNN3 HNRNPH1 HNRNPH2 AGAP2	3.30e-03	1018	63	9	GO:0098794
Domain	S100_CABP	FLG TCHHL1 HRNR FLG2	2.07e-06	27	64	4	PS00303
Domain	S_100	FLG TCHHL1 HRNR FLG2	2.07e-06	27	64	4	PF01023
Domain	S100_Ca-bd_sub	FLG TCHHL1 HRNR FLG2	2.41e-06	28	64	4	IPR013787
Domain	S_100	FLG TCHHL1 HRNR FLG2	2.41e-06	28	64	4	SM01394
Domain	Filaggrin	FLG FLG2	1.16e-05	2	64	2	IPR003303
Domain	zf-RNPHF	HNRNPH1 HNRNPH2	3.46e-05	3	64	2	PF08080
Domain	Znf_CHHC	HNRNPH1 HNRNPH2	3.46e-05	3	64	2	IPR012996
Domain	S100/CaBP-9k_CS	FLG HRNR FLG2	1.18e-04	28	64	3	IPR001751
Domain	ArfGap	GIT1 AGAP2 AGAP3	1.32e-04	29	64	3	SM00105
Domain	ArfGap	GIT1 AGAP2 AGAP3	1.32e-04	29	64	3	PF01412
Domain	ARFGAP	GIT1 AGAP2 AGAP3	1.32e-04	29	64	3	PS50115
Domain	ArfGAP	GIT1 AGAP2 AGAP3	1.32e-04	29	64	3	IPR001164
Domain	MHC_I_a_C	HLA-A HLA-B	1.72e-04	6	64	2	IPR010579
Domain	MHC_I_C	HLA-A HLA-B	1.72e-04	6	64	2	PF06623
Domain	Roc	AGAP2 AGAP3	8.80e-04	13	64	2	PF08477
Domain	MIRO-like	AGAP2 AGAP3	8.80e-04	13	64	2	IPR013684
Domain	PH	TIAM1 DOK4 PSD3 AGAP2 AGAP3	1.12e-03	229	64	5	PF00169
Domain	-	FLG TCHHL1 HRNR FLG2 STAT5B	2.00e-03	261	64	5	1.10.238.10
Domain	-	TIAM1 DOK4 PSD3 EPB41L3 AGAP2 AGAP3	2.18e-03	391	64	6	2.30.29.30
Domain	MHC_I	HLA-A HLA-B	2.33e-03	21	64	2	PF00129
Domain	MHC_I_a_a1/a2	HLA-A HLA-B	2.33e-03	21	64	2	IPR001039
Domain	PH	TIAM1 DOK4 PSD3 AGAP2 AGAP3	2.63e-03	278	64	5	SM00233
Domain	PH_DOMAIN	TIAM1 DOK4 PSD3 AGAP2 AGAP3	2.67e-03	279	64	5	PS50003
Domain	PH_domain	TIAM1 DOK4 PSD3 AGAP2 AGAP3	2.71e-03	280	64	5	IPR001849
Domain	EF-hand-dom_pair	FLG TCHHL1 HRNR FLG2 STAT5B	3.01e-03	287	64	5	IPR011992
Domain	-	HLA-A HLA-B	3.04e-03	24	64	2	3.30.500.10
Domain	MHC_I-like_Ag-recog	HLA-A HLA-B	3.04e-03	24	64	2	IPR011161
Domain	SH3_2	TSPOAP1 SAMSN1 MYO15A	3.21e-03	86	64	3	IPR011511
Domain	SH3_2	TSPOAP1 SAMSN1 MYO15A	3.21e-03	86	64	3	PF07653
Domain	PH_dom-like	TIAM1 DOK4 PSD3 EPB41L3 AGAP2 AGAP3	3.34e-03	426	64	6	IPR011993
Domain	MHC_I/II-like_Ag-recog	HLA-A HLA-B	7.51e-03	38	64	2	IPR011162
Pathway	BIOCARTA_NKCELLS_PATHWAY	LAT HLA-A HLA-B	1.03e-04	25	52	3	MM1465
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B	1.98e-04	6	52	2	M47468
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B	2.77e-04	7	52	2	M47582
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B	2.77e-04	7	52	2	M47530
Pathway	REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5	EPOR STAT5B	2.77e-04	7	52	2	M27907
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-B	4.73e-04	9	52	2	MM14527
Pathway	KEGG_ENDOCYTOSIS	HLA-A HLA-B GIT1 PSD3 AGAP2	5.26e-04	181	52	5	M1519
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	HLA-A TIAM1 HLA-B IFT88 GIT1 MYCBP2 DNAJA2 UBR4 NCKAP5 PBX1 ADARB1 BHLHE40 AFF4 STAT5B AGAP2 AGAP3	1.29e-09	1285	65	16	35914814
Pubmed	Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.	FLG HRNR FLG2	6.23e-09	3	65	3	23403047
Pubmed	hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling.	FLG HLA-A DNAJA2 A2ML1 HRNR FLG2 HNRNPH1 HNRNPH2	2.73e-07	346	65	8	25324306
Pubmed	Ring finger protein 12 activates AKT signalling to promote the progression of liver cancer by interacting with EGFR.	KRT24 RBM14 HRNR FLG2 HNRNPH1 HNRNPH2 LRCH3	1.17e-06	289	65	7	37132043
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	MAN2B1 P3H1 AGA DNAJA2 HRNR FLG2 EPB41L3 HNRNPH1 HNRNPH2	2.06e-06	613	65	9	22268729
Pubmed	Association of HLA-A11:01, -A24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study.	HLA-A HLA-B	3.44e-06	2	65	2	37895076
Pubmed	Study of HLA Class I gene in Indian schizophrenic patients of Siliguri, West Bengal.	HLA-A HLA-B	3.44e-06	2	65	2	21459456
Pubmed	HLA-B27 subtypes determination in patients with ankylosing spondylitis from Zulia, Venezuela.	HLA-A HLA-B	3.44e-06	2	65	2	12826378
Pubmed	Separate developmental programs for HLA-A and -B cell surface expression during differentiation from embryonic stem cells to lymphocytes, adipocytes and osteoblasts.	HLA-A HLA-B	3.44e-06	2	65	2	23349864
Pubmed	Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.	HLA-A HLA-B	3.44e-06	2	65	2	20032191
Pubmed	The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.	HLA-A HLA-B	3.44e-06	2	65	2	11752149
Pubmed	Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population.	HLA-A HLA-B	3.44e-06	2	65	2	29350020
Pubmed	Distributions of HLA class I alleles and haplotypes in Bulgarians--contribution to understanding the origin of the population.	HLA-A HLA-B	3.44e-06	2	65	2	11285128
Pubmed	HLA-A and -B alleles and haplotypes in 240 index patients with common variable immunodeficiency and selective IgG subclass deficiency in central Alabama.	HLA-A HLA-B	3.44e-06	2	65	2	12803653
Pubmed	Association of HLA genotypes with phenobarbital hypersensitivity in children.	HLA-A HLA-B	3.44e-06	2	65	2	27554620
Pubmed	Proline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen.	HLA-A HLA-B	3.44e-06	2	65	2	12502873
Pubmed	HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia.	HLA-A HLA-B	3.44e-06	2	65	2	24084328
Pubmed	HLA-A and HLA-B allele frequencies in a mestizo population from Guadalajara, Mexico, determined by sequence-based typing.	HLA-A HLA-B	3.44e-06	2	65	2	16305683
Pubmed	Maternal versus paternal inheritance of HLA class I alleles among HIV-infected children: consequences for clinical disease progression.	HLA-A HLA-B	3.44e-06	2	65	2	15362660
Pubmed	Absence of HLA-B1502 and HLA-A3101 alleles in 9 Korean patients with antiepileptic drug-induced skin rash: a preliminary study.	HLA-A HLA-B	3.44e-06	2	65	2	25187890
Pubmed	Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgia.	HLA-A HLA-B	3.44e-06	2	65	2	25355886
Pubmed	HLA-associated immune pressure on Gag protein in CRF01_AE-infected individuals and its association with plasma viral load.	HLA-A HLA-B	3.44e-06	2	65	2	20567513
Pubmed	Accuracy of SNPs to predict risk of HLA alleles associated with drug-induced hypersensitivity events across racial groups.	HLA-A HLA-B	3.44e-06	2	65	2	26083016
Pubmed	Atopic Dermatitis Susceptibility Variants in Filaggrin Hitchhike Hornerin Selective Sweep.	FLG HRNR	3.44e-06	2	65	2	27678121
Pubmed	HLA A*02 allele frequencies and B haplotype associations in Western Indians.	HLA-A HLA-B	3.44e-06	2	65	2	12691707
Pubmed	Cell surface expression level variation between two common Human Leukocyte Antigen alleles, HLA-A2 and HLA-B8, is dependent on the structure of the C terminal part of the alpha 2 and the alpha 3 domains.	HLA-A HLA-B	3.44e-06	2	65	2	26258424
Pubmed	Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome.	HLA-A HLA-B	3.44e-06	2	65	2	26375851
Pubmed	Association analysis between HLA-A, -B, -C, -DRB1, and -DQB1 with nasopharyngeal carcinoma among a Han population in Northwestern China.	HLA-A HLA-B	3.44e-06	2	65	2	24389314
Pubmed	HLA-A26, HLA-B4002, HLA-B4006, and HLA-B4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.	HLA-A HLA-B	3.44e-06	2	65	2	11485622
Pubmed	[Polymorphism research on the distribution of four HLA alleles in five Chinese populations].	HLA-A HLA-B	3.44e-06	2	65	2	16120569
Pubmed	Disparate binding of chaperone proteins by HLA-A subtypes.	HLA-A HLA-B	3.44e-06	2	65	2	11862383
Pubmed	[Analysis of HPA1-16 and HLA-A, B gene polymorphisms among ethnic Han population from Shandong].	HLA-A HLA-B	3.44e-06	2	65	2	27577225
Pubmed	The frequency of HLA class I alleles in Japanese patients with bone marrow failure.	HLA-A HLA-B	3.44e-06	2	65	2	16704965
Pubmed	The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles.	HLA-A HLA-B	3.44e-06	2	65	2	7761977
Pubmed	HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis.	HLA-A HLA-B	3.44e-06	2	65	2	11903375
Pubmed	HLA class I alleles associated with susceptibility or resistance to human immunodeficiency virus type 1 infection among a population in Chaco Province, Argentina.	HLA-A HLA-B	3.44e-06	2	65	2	11010837
Pubmed	Susceptible and protective HLA class 1 alleles against dengue fever and dengue hemorrhagic fever patients in a Malaysian population.	HLA-A HLA-B	3.44e-06	2	65	2	20927388
Pubmed	The association and linkage of the HLA-A2 class I allele with autism.	HLA-A HLA-B	3.44e-06	2	65	2	16720216
Pubmed	Cutting Edge: Epitope-dependent effect of Nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication.	HLA-A HLA-B	3.44e-06	2	65	2	15611225
Pubmed	Polymorphism of HLA-A and HLA-B in pre-eclampsia.	HLA-A HLA-B	3.44e-06	2	65	2	19727231
Pubmed	Predicting the impact of blocking human immunodeficiency virus type 1 Nef in vivo.	HLA-A HLA-B	3.44e-06	2	65	2	19091857
Pubmed	Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking.	HLA-A HLA-B	3.44e-06	2	65	2	9971776
Pubmed	A novel multiplex polymerase chain reaction assay for detection of both HLA-A31:01/HLA-B15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions.	HLA-A HLA-B	3.44e-06	2	65	2	28884973
Pubmed	Class I HLA Allele Predicted Restricted Antigenic Coverages for Spike and Nucleocapsid Proteins Are Associated With Deaths Related to COVID-19.	HLA-A HLA-B	3.44e-06	2	65	2	33391255
Pubmed	A comparative study of HLA binding affinity and ligand diversity: implications for generating immunodominant CD8+ T cell responses.	HLA-A HLA-B	3.44e-06	2	65	2	19155500
Pubmed	HLA class I variation in the West African Pygmies and their genetic relationship with other African populations.	HLA-A HLA-B	3.44e-06	2	65	2	12956877
Pubmed	Characterization of three new HLA Class I Alleles in Spanish Caucasians, HLA-A02:620, HLA-B27:150 and HLA-B*07:05:01:02.	HLA-A HLA-B	3.44e-06	2	65	2	28383785
Pubmed	[Association of HLA-A, B antigens with susceptibility to advanced endometriosis in Koreans].	HLA-A HLA-B	3.44e-06	2	65	2	18458507
Pubmed	Human herpesvirus 6B immediate-early I protein contains functional HLA-A02, HLA-A03, and HLA-B*07 class I restricted CD8(+) T-cell epitopes.	HLA-A HLA-B	3.44e-06	2	65	2	25243920
Pubmed	Polymorphisms of HLA-A and HLA-B genes in genetic susceptibility to esophageal carcinoma in Chaoshan Han Chinese.	HLA-A HLA-B	3.44e-06	2	65	2	19392852
Pubmed	Possible role of deep tubular invaginations of the plasma membrane in MHC-I trafficking.	HLA-A HLA-B	3.44e-06	2	65	2	15878340
Pubmed	Epstein-Barr virus latent membrane protein 2A mediated activation of Sonic Hedgehog pathway induces HLA class Ia downregulation in gastric cancer cells.	HLA-A HLA-B	3.44e-06	2	65	2	26057149
Pubmed	Somatic mutations in the HLA genes of patients with hematological malignancy.	HLA-A HLA-B	3.44e-06	2	65	2	22489945
Pubmed	HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central Alabama.	HLA-A HLA-B	3.44e-06	2	65	2	12370085
Pubmed	Relationship between primary nodal generalized osteoarthritis with tissue antigens HLA-A and HLA-B in the western Black Sea region of Turkey.	HLA-A HLA-B	3.44e-06	2	65	2	21422676
Pubmed	Comparisons of CVID and IgGSD: referring physicians, autoimmune conditions, pneumovax reactivity, immunoglobulin levels, blood lymphocyte subsets, and HLA-A and -B typing in 432 adult index patients.	HLA-A HLA-B	3.44e-06	2	65	2	25295286
Pubmed	An association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.	HLA-A HLA-B	3.44e-06	2	65	2	12437654
Pubmed	Collaboration of a Detrimental HLA-B35:01 Allele with HLA-A24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes.	HLA-A HLA-B	3.44e-06	2	65	2	34523962
Pubmed	Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.	HLA-A HLA-B	3.44e-06	2	65	2	14989713
Pubmed	HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.	HLA-A HLA-B	3.44e-06	2	65	2	23588310
Pubmed	HLA-B4431: a new HLA-B variant with a complex ancestral history involving HLA-B44, B40 and B07 alleles.	HLA-A HLA-B	3.44e-06	2	65	2	12366789
Pubmed	HLA-B*3531, a hybrid of B35 and B61, implications for diagnostic approaches to alleles with complex ancestral compositions.	HLA-A HLA-B	3.44e-06	2	65	2	12366790
Pubmed	The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.	HLA-A HLA-B	3.44e-06	2	65	2	2420472
Pubmed	HLA-B27 polymorphism in the Malays.	HLA-A HLA-B	3.44e-06	2	65	2	12974801
Pubmed	Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.	HLA-A HLA-B	3.44e-06	2	65	2	22613796
Pubmed	Detection and measurement of a single blood cell surface antigen by thermal lens microscopy.	HLA-A HLA-B	3.44e-06	2	65	2	10929804
Pubmed	Genetic link between Chaoshan and other Chinese Han populations: Evidence from HLA-A and HLA-B allele frequency distribution.	HLA-A HLA-B	3.44e-06	2	65	2	16883565
Pubmed	Evolution of HLA-class I compared to HLA-class II polymorphism in Terena, a South-American Indian tribe.	HLA-A HLA-B	3.44e-06	2	65	2	10600013
Pubmed	[Influence of HLA-A, B loci carrying Bw4 motif on HIV CD4 T cell count and viral load].	HLA-A HLA-B	3.44e-06	2	65	2	21029668
Pubmed	Independent strong association of HLA-A02:06 and HLA-B44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement.	HLA-A HLA-B	3.44e-06	2	65	2	24781922
Pubmed	Associations of Human Leukocyte Antigen (HLA) haplotypes with risk of developing lymphoproliferative disorders after renal transplantation.	HLA-A HLA-B	3.44e-06	2	65	2	18344933
Pubmed	Gliadin-Specific CD8+ T Cell Responses Restricted by HLA Class I A0101 and B0801 Molecules in Celiac Disease Patients.	HLA-A HLA-B	3.44e-06	2	65	2	28148736
Pubmed	Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.	HLA-A HLA-B	3.44e-06	2	65	2	18004301
Pubmed	Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes.	HLA-A HLA-B	3.44e-06	2	65	2	19536817
Pubmed	HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection.	HLA-A HLA-B	3.44e-06	2	65	2	24737799
Pubmed	The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.	HLA-A HLA-B	3.44e-06	2	65	2	10403641
Pubmed	Human leukocyte class I antigen alleles A2 and A11 are not associated with nasopharyngeal carcinoma in West Malaysia.	HLA-A HLA-B	3.44e-06	2	65	2	17609824
Pubmed	Genetics of Behçet disease inside and outside the MHC.	HLA-A HLA-B	3.44e-06	2	65	2	19684014
Pubmed	Selective downmodulation of HLA-A and -B by Nef alleles from different groups of primate lentiviruses.	HLA-A HLA-B	3.44e-06	2	65	2	18155264
Pubmed	Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese.	HLA-A HLA-B	3.44e-06	2	65	2	15726104
Pubmed	Fibromyalgia in 300 adult index patients with primary immunodeficiency.	HLA-A HLA-B	3.44e-06	2	65	2	28422000
Pubmed	[Four-digit allele genotyping of HLA-A and HLA-B genes in Japanese patients with Behçet's disease (BD) by a PCR-SSOP-luminex method and stratification analysis according to each major symptom of BD].	HLA-A HLA-B	3.44e-06	2	65	2	18517005
Pubmed	HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients.	HLA-A HLA-B	3.44e-06	2	65	2	15113995
Pubmed	Distinctive HLA-A,B antigens of black populations formed by interallelic conversion.	HLA-A HLA-B	3.44e-06	2	65	2	1431115
Pubmed	HLA-A and HLA-B gene polymorphism and idiopathic pulmonary fibrosis in a Han Chinese population.	HLA-A HLA-B	3.44e-06	2	65	2	22784404
Pubmed	A Microsatellite in the Coding Sequence of HLA-A/B Is a Mutation Hotspot in Colon Cancer With Microsatellite Instability.	HLA-A HLA-B	3.44e-06	2	65	2	34653421
Pubmed	Trans-ethnic study confirmed independent associations of HLA-A02:06 and HLA-B44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications.	HLA-A HLA-B	3.44e-06	2	65	2	25099678
Pubmed	Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.	HLA-A HLA-B	3.44e-06	2	65	2	12029127
Pubmed	Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan.	HLA-A HLA-B	3.44e-06	2	65	2	19683024
Pubmed	Diversity is demonstrated in class I HLA-A and HLA-B alleles in Cameroon, Africa: description of HLA-A03012, 2612, 3006 and HLA-B1403, 4016, 4703.	HLA-A HLA-B	3.44e-06	2	65	2	11098929
Pubmed	HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infection.	HLA-A HLA-B	3.44e-06	2	65	2	20800922
Pubmed	Novel HLA-A and HLA-B alleles.	HLA-A HLA-B	3.44e-06	2	65	2	9714480
Pubmed	Association between HLA-A and -B polymorphisms and susceptibility to Henoch-Schönlein purpura in Han and Mongolian children from Inner Mongolia.	HLA-A HLA-B	3.44e-06	2	65	2	22370889
Pubmed	Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.	HLA-A HLA-B	3.44e-06	2	65	2	19920778
Pubmed	[Comparative studies of serological typing and HLA-A, B antigen genotyping with PCR using sequence-specific primers].	HLA-A HLA-B	3.44e-06	2	65	2	15567775
Pubmed	[Cloning and sequencing HLA-A and -B genomic DNA and analyzing polymorphism in regulatory regions in Chinese Han individuals].	HLA-A HLA-B	3.44e-06	2	65	2	20650849
Pubmed	Recommendations for HLA-B15:02 and HLA-A31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions.	HLA-A HLA-B	3.44e-06	2	65	2	24597466
Pubmed	A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemia.	HLA-A HLA-B	3.44e-06	2	65	2	32439725
Pubmed	HLA-A*2402 and a microsatellite (D6S248) are secondary independent susceptibility markers to ankylosing spondylitis in Basque patients.	HLA-A HLA-B	3.44e-06	2	65	2	14969772
Pubmed	Three-loci HLA haplotypes in Spanish celiac children and healthy subjects: estimation of linkage disequilibrium and haplotype frequencies.	HLA-A HLA-B	3.44e-06	2	65	2	11374682
Interaction	MIR9-3 interactions	P3H1 RBM14 ADARB1 HNRNPH1 HNRNPH2	2.84e-06	70	64	5	int:MIR9-3
Interaction	MIR92A1 interactions	P3H1 RBM14 ADARB1 HNRNPH1 HNRNPH2	4.86e-06	78	64	5	int:MIR92A1
Interaction	MIR1-2 interactions	P3H1 RBM14 ADARB1 HNRNPH1 HNRNPH2	5.18e-06	79	64	5	int:MIR1-2
Interaction	SAMD12 interactions	FLG TMEM132D HRNR	8.54e-06	13	64	3	int:SAMD12
Interaction	MIR141 interactions	P3H1 RBM14 ADARB1 HNRNPH1 HNRNPH2	8.81e-06	88	64	5	int:MIR141
Interaction	MIRLET7B interactions	P3H1 RBM14 ADARB1 HNRNPH1 HNRNPH2	1.73e-05	101	64	5	int:MIRLET7B
Interaction	ARRDC2 interactions	UBR4 PEX1 BOD1L1 EPB41L3	2.60e-05	54	64	4	int:ARRDC2
Interaction	TXNIP interactions	FLG MYCBP2 DNAJA2 UBR4 HRNR EPB41L3	5.69e-05	212	64	6	int:TXNIP
Interaction	MIR138-1 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	6.47e-05	68	64	4	int:MIR138-1
Interaction	CD8A interactions	LAT HLA-A HLA-B	7.54e-05	26	64	3	int:CD8A
Interaction	MIR140 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	7.66e-05	71	64	4	int:MIR140
Interaction	MIR29B2 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	7.66e-05	71	64	4	int:MIR29B2
Interaction	COPRS interactions	EPB41L3 HNRNPH1 HNRNPH2 WDTC1	7.66e-05	71	64	4	int:COPRS
Interaction	POU5F1 interactions	OTX2 P3H1 DNAJA2 UBR4 RBM14 MUC16 SOX8 CNN3 PHC1	9.01e-05	584	64	9	int:POU5F1
Interaction	ARF6 interactions	HLA-A TIAM1 GIT1 DNAJA2 PSD3 EPB41L3 HNRNPH1 CDKAL1 AGAP3	9.01e-05	584	64	9	int:ARF6
Interaction	SH2D3A interactions	FLG AGA A2ML1 FLG2	9.49e-05	75	64	4	int:SH2D3A
Interaction	MIR7-3 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.00e-04	76	64	4	int:MIR7-3
Interaction	MIR199A2 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.00e-04	76	64	4	int:MIR199A2
Interaction	D2HGDH interactions	GIT1 ABHD10 PEX1 VPS13B HNRNPH1	1.01e-04	146	64	5	int:D2HGDH
Interaction	MIR9-2 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.05e-04	77	64	4	int:MIR9-2
Interaction	MIR200A interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.05e-04	77	64	4	int:MIR200A
Interaction	MIR98 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.11e-04	78	64	4	int:MIR98
Interaction	MIR222 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.16e-04	79	64	4	int:MIR222
Interaction	MIR206 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.16e-04	79	64	4	int:MIR206
Interaction	MIR143 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.22e-04	80	64	4	int:MIR143
Interaction	MIR145 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.28e-04	81	64	4	int:MIR145
Interaction	MIR106A interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.41e-04	83	64	4	int:MIR106A
Interaction	MIR31 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.47e-04	84	64	4	int:MIR31
Interaction	MIR7-2 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.47e-04	84	64	4	int:MIR7-2
Interaction	MIR200B interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.47e-04	84	64	4	int:MIR200B
Interaction	MIR107 interactions	P3H1 RBM14 HNRNPH1 HNRNPH2	1.54e-04	85	64	4	int:MIR107
Interaction	MIR18B interactions	P3H1 RBM14 HNRNPH1 HNRNPH2	1.54e-04	85	64	4	int:MIR18B
Interaction	MIR9-1 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.54e-04	85	64	4	int:MIR9-1
Interaction	MIR16-2 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.54e-04	85	64	4	int:MIR16-2
Interaction	WEE2-AS1 interactions	FLG FLG2 HNRNPH1 HNRNPH2 STAT5B	1.69e-04	163	64	5	int:WEE2-AS1
Interaction	EGLN3 interactions	NHSL1 EPOR HLA-A HLA-B MYCBP2 P3H1 ABHD10 DNAJA2 UBR4 PEX1 CNN3 CDKAL1 LRCH3	1.83e-04	1296	64	13	int:EGLN3
Interaction	MIR29C interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.84e-04	89	64	4	int:MIR29C
Interaction	PI4KAP1 interactions	FLG A2ML1 FLG2	1.86e-04	35	64	3	int:PI4KAP1
Interaction	MIR221 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.93e-04	90	64	4	int:MIR221
Interaction	MIR92A2 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.93e-04	90	64	4	int:MIR92A2
Interaction	MIR1-1 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	1.93e-04	90	64	4	int:MIR1-1
Interaction	CCDC120 interactions	IFT88 LZTS1 P3H1 PBX1 HNRNPH1	2.00e-04	169	64	5	int:CCDC120
Interaction	B4GALNT2 interactions	OTX2 HNRNPH1	2.06e-04	7	64	2	int:B4GALNT2
Interaction	MIR155 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	2.10e-04	92	64	4	int:MIR155
Interaction	WAPL interactions	PSD3 FLG2 ADARB1 HNRNPH1 WDTC1	2.23e-04	173	64	5	int:WAPL
Interaction	MIR19B2 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	2.28e-04	94	64	4	int:MIR19B2
Interaction	MIRLET7F1 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	2.28e-04	94	64	4	int:MIRLET7F1
Interaction	SRC interactions	EPOR HLA-A TIAM1 HLA-B DOK4 GIT1 EPB41L3 STAT5B AGAP2	2.36e-04	664	64	9	int:SRC
Interaction	RLIM interactions	KRT24 RBM14 HRNR FLG2 HNRNPH1 HNRNPH2 LRCH3	2.39e-04	392	64	7	int:RLIM
Interaction	MIRLET7A2 interactions	P3H1 RBM14 HNRNPH1 HNRNPH2	2.47e-04	96	64	4	int:MIRLET7A2
Interaction	MIRLET7C interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	2.57e-04	97	64	4	int:MIRLET7C
Interaction	MIRLET7F2 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	2.57e-04	97	64	4	int:MIRLET7F2
Interaction	MIR363 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	2.57e-04	97	64	4	int:MIR363
Interaction	MIR19A interactions	P3H1 RBM14 HNRNPH1 HNRNPH2	2.89e-04	100	64	4	int:MIR19A
Interaction	GRIA4 interactions	TRO RBM14 EPB41L3	2.99e-04	41	64	3	int:GRIA4
Interaction	MIRLET7A3 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	3.11e-04	102	64	4	int:MIRLET7A3
Interaction	NAA50 interactions	OTX2 BHLHE40 HNRNPH1 CDKAL1	3.11e-04	102	64	4	int:NAA50
Interaction	GATA4 interactions	DNAJA2 RBM14 PBX1 BHLHE40 HNRNPH1 HNRNPH2 PHC1	3.18e-04	411	64	7	int:GATA4
Interaction	HOXC4 interactions	SOX8 PBX1 HNRNPH1	3.21e-04	42	64	3	int:HOXC4
Interaction	MIR15B interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	3.23e-04	103	64	4	int:MIR15B
Interaction	MIR19B1 interactions	P3H1 RBM14 HNRNPH1 HNRNPH2	3.35e-04	104	64	4	int:MIR19B1
Interaction	MIR34A interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	3.35e-04	104	64	4	int:MIR34A
Interaction	ZCCHC17 interactions	EPB41L3 ADARB1 HNRNPH1 WDTC1	3.35e-04	104	64	4	int:ZCCHC17
Interaction	ELP2 interactions	DNAJA2 UBR4 AFF4 STAT5B	3.48e-04	105	64	4	int:ELP2
Interaction	STXBP1 interactions	GIT1 UBR4 PSD3 EPB41L3 AGAP2	3.52e-04	191	64	5	int:STXBP1
Interaction	USP9X interactions	LAT TIAM1 UBR4 RBM14 PBX1 HNRNPH1 AGAP2	3.73e-04	422	64	7	int:USP9X
Interaction	MIRLET7A1 interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	3.87e-04	108	64	4	int:MIRLET7A1
Interaction	MIR34B interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	4.15e-04	110	64	4	int:MIR34B
Interaction	FBXO6 interactions	MAN2B1 P3H1 AGA DNAJA2 HRNR FLG2 EPB41L3 HNRNPH1 HNRNPH2	4.15e-04	717	64	9	int:FBXO6
Interaction	LILRB1 interactions	HLA-A HLA-B	4.39e-04	10	64	2	int:LILRB1
Interaction	LILRB2 interactions	HLA-A HLA-B	4.39e-04	10	64	2	int:LILRB2
Interaction	RAB35 interactions	HLA-A TIAM1 HLA-B RBM14 PSD3 EPB41L3 HNRNPH1 CDKAL1	4.44e-04	573	64	8	int:RAB35
Interaction	MIRLET7I interactions	P3H1 RBM14 HNRNPH1 HNRNPH2	4.75e-04	114	64	4	int:MIRLET7I
Interaction	YWHAG interactions	NHSL1 TIAM1 GIT1 MYCBP2 RBM14 PSD3 BOD1L1 SAMSN1 EPB41L3 HNRNPH1 LRCH3 AGAP3	4.93e-04	1248	64	12	int:YWHAG
Interaction	MIRLET7G interactions	RBM14 ADARB1 HNRNPH1 HNRNPH2	5.24e-04	117	64	4	int:MIRLET7G
Interaction	AGAP1 interactions	TIAM1 NCKAP5 EPB41L3 AGAP3	5.24e-04	117	64	4	int:AGAP1
Interaction	ZFPL1 interactions	HLA-A TIAM1 A2ML1 PSD3 EPB41L3 VPS13B WDTC1	5.33e-04	448	64	7	int:ZFPL1
Interaction	ATPSCKMT interactions	HNRNPH1 WDTC1	5.36e-04	11	64	2	int:ATPSCKMT
Interaction	CUL2 interactions	FLG EPOR KRT24 RBM14 HRNR FLG2 HNRNPH1 HNRNPH2	5.44e-04	591	64	8	int:CUL2
Interaction	RPS6KL1 interactions	UBR4 RBM14 HNRNPH1	5.71e-04	51	64	3	int:RPS6KL1
Interaction	WDR82 interactions	RBM14 BOD1L1 ADARB1 HNRNPH1 WDTC1	5.78e-04	213	64	5	int:WDR82
Interaction	GPN1 interactions	P3H1 A2ML1 HNRNPH1 HNRNPH2	6.33e-04	123	64	4	int:GPN1
Interaction	NCKAP1 interactions	NHSL1 TMEM132D EPB41L3 HNRNPH1 AGAP2	6.42e-04	218	64	5	int:NCKAP1
Interaction	UBR4 interactions	IFT88 MYCBP2 ABHD10 UBR4 BOD1L1 PBX1	6.62e-04	334	64	6	int:UBR4
Interaction	ELK1 interactions	DOK4 DNAJA2 HNRNPH1 AGAP3	6.72e-04	125	64	4	int:ELK1
Interaction	SLC7A6 interactions	LZTS1 CNN3 HNRNPH1	7.12e-04	55	64	3	int:SLC7A6
Interaction	DCLK1 interactions	TIAM1 MYCBP2 AGAP2 WDTC1	7.13e-04	127	64	4	int:DCLK1
Interaction	CCNT1 interactions	TIAM1 EPB41L3 ADARB1 HNRNPH1 AFF4	7.41e-04	225	64	5	int:CCNT1
Interaction	USP7 interactions	TMEM132D TRO RBM14 UPRT HPSE2 HRNR FLG2 ADARB1 VPS13B HNRNPH1 HNRNPH2 AFF4	7.74e-04	1313	64	12	int:USP7
Interaction	ZNHIT1 interactions	OTX2 GIT1 P3H1	7.91e-04	57	64	3	int:ZNHIT1
Interaction	TRPV1 interactions	RBM14 EPB41L3 HNRNPH1 HNRNPH2	8.01e-04	131	64	4	int:TRPV1
Interaction	STAT5A interactions	EPOR HNRNPH1 STAT5B AGAP2	8.01e-04	131	64	4	int:STAT5A
Interaction	WDR45 interactions	MYCBP2 DNAJA2 WDTC1	8.32e-04	58	64	3	int:WDR45
Interaction	UCK2 interactions	UPRT HNRNPH1 WDTC1	8.32e-04	58	64	3	int:UCK2
Interaction	SKP1 interactions	MAN2B1 GIT1 MYCBP2 RBM14 BHLHE40 PHC1 WDTC1	8.41e-04	484	64	7	int:SKP1
Interaction	SACS interactions	DNAJA2 HNRNPH1 AGAP2	8.75e-04	59	64	3	int:SACS
Interaction	IQSEC3 interactions	MYCBP2 AGAP2	8.81e-04	14	64	2	int:IQSEC3
Cytoband	1q21.3	FLG TCHHL1 HRNR FLG2	2.41e-05	117	65	4	1q21.3
GeneFamily	EF-hand domain containing\|S100 fused type protein family	FLG TCHHL1 HRNR FLG2	1.66e-09	7	49	4	1350
GeneFamily	ArfGAPs	GIT1 AGAP2 AGAP3	9.64e-05	33	49	3	395
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TIAM1 DOK4 PSD3 AGAP2 AGAP3	2.32e-04	206	49	5	682
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	AGAP2 AGAP3	9.53e-04	17	49	2	1291
GeneFamily	C1-set domain containing	HLA-A HLA-B	5.78e-03	42	49	2	591
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-A HLA-B	6.33e-03	44	49	2	588
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO15A EPB41L3	8.11e-03	50	49	2	1293
GeneFamily	Fibronectin type III domain containing	EPOR TSPOAP1 CNTN5	9.30e-03	160	49	3	555
Coexpression	GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN	HLA-A HLA-B MYCBP2 BOD1L1 CNN3 AFF4	8.74e-06	194	65	6	M7306
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200	MUC16 HPSE2 BHLHE40	3.04e-05	21	62	3	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_200
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	LZTS1 PSD3 MYO15A KCNH3 AGAP2 AGAP3	7.74e-08	147	65	6	8f725ff8fb4ced5db2643e80669d3f7945b820ab
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	GIT1 TSPOAP1 TRO PSD3 HPSE2	5.29e-06	172	65	5	c6bc78fd63c9479a84ec0552b55c89750cad0fa5
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	GIT1 TSPOAP1 TRO PSD3 HPSE2	5.29e-06	172	65	5	bfb87a281a9cf6ad45b310bf8104fc0ab382b549
ToppCell	343B-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	EPOR GIT1 P3H1 PEX1 AGAP3	7.53e-06	185	65	5	1b8e3ddb91797f84e4b15d2457b0c008e5be50db
ToppCell	343B-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	EPOR GIT1 P3H1 PEX1 AGAP3	7.53e-06	185	65	5	02cbf492bc40abebaa93a3a208888afae72fbe06
ToppCell	tumor_Lung-T/NK_cells-Exhausted_Tfh\|tumor_Lung / Location, Cell class and cell subclass	HLA-A TIAM1 HLA-B SAMSN1 STAT5B	8.79e-06	191	65	5	3e259eba83f8159d1a1a96b98d0e867fe547c5e7
ToppCell	normal_Pleural_Fluid-T/NK_cells-CD8_low_T\|T/NK_cells / Location, Cell class and cell subclass	HLA-A HLA-B LZTS1 ADARB1 BHLHE40	9.48e-06	194	65	5	cf2480cc40f3c9be837b3934547e2ce30bd4fcd3
ToppCell	normal_Lymph_Node-T/NK_cells-CD4+_Th\|normal_Lymph_Node / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1 BHLHE40	9.48e-06	194	65	5	208b56b2a1f5494b74f9423f2bdc2eb6d6023fa9
ToppCell	tumor_Lung-T/NK_cells-Exhausted_Tfh\|T/NK_cells / Location, Cell class and cell subclass	HLA-A TIAM1 HLA-B SAMSN1 STAT5B	9.96e-06	196	65	5	5a0b5aeff7e535781ea2a4c85799bb468afcb6f8
ToppCell	(5)_Dendritic_cell-(53)_Lymphoid_DC\|(5)_Dendritic_cell / shred on Cell_type and subtype	PSD3 SAMSN1 CNN3 KCNH3 LRCH3	1.05e-05	198	65	5	548da5fa86f9756c503ed77bcdde55bc4d1a2726
ToppCell	Biopsy_Control_(H.)-Immune-Mast_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	LAT TRO SAMSN1 PBX1 BHLHE40	1.10e-05	200	65	5	64bf125e0e5652a5a638a6bb32eb109cb0d5e232
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	TMEM132D CNTN5 MUC16 HPSE2	5.10e-05	139	65	4	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KRT24 LAT SAMSN1 AGAP2	7.60e-05	154	65	4	d0a1ff02a7e91f6923aa85b65094f78e357e377d
ToppCell	facs-Large_Intestine-Proximal-24m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT24 LAT SAMSN1 KCNH3	9.02e-05	161	65	4	cb4921da94b3355d5234b389aa3ec15939607cd5
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT24 LAT SAMSN1 KCNH3	9.02e-05	161	65	4	9edcab51da01a84cfe6166ed4c1f951a4ceeac55
ToppCell	facs-GAT-Fat-24m-Lymphocytic-NK_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAT CNTN5 UPRT AGAP2	9.46e-05	163	65	4	e58863a462cc504bced627f004a47890ee2307ce
ToppCell	facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l26\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPOR LAT SAMSN1 AGAP2	9.92e-05	165	65	4	23955e3373660f827518e723ac62fba99753f375
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Th1\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LZTS1 TRO SAMSN1 BHLHE40	1.04e-04	167	65	4	9c55ec8f70b86d4d3d5c2a6ecd9bff2dafe68c11
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAN2B1 LAT SAMSN1 AGAP2	1.09e-04	169	65	4	b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b
ToppCell	metastatic_Lymph_Node-T/NK_cells-Exhausted_Tfh\|metastatic_Lymph_Node / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.09e-04	169	65	4	ad9054ee09033b648a76baf1b2ec4a6ab1394bde
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAN2B1 LAT SAMSN1 AGAP2	1.09e-04	169	65	4	83d1bcf33872b01ea9614f608a3e4ab30df25c7e
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KRT24 MUC16 BHLHE40 HNRNPH1	1.22e-04	174	65	4	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAN2B1 DSPP CNTN5 SAMSN1	1.24e-04	175	65	4	1d1928581a4df5f9e3398f9bf3334990e39f9851
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAT HLA-A HLA-B AGAP2	1.24e-04	175	65	4	dddeced0cfcf71d03bcf349983908b3bfb0ab51d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	LAT SAMSN1 MYO15A STAT5B	1.30e-04	177	65	4	f4ddf0ef0eade13b9835a5684a8dbb6f71be4697
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Mast_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAT TIAM1 SAMSN1 BHLHE40	1.30e-04	177	65	4	15553c7cd7826c80086daa76af4224f32dde53a6
ToppCell	facs-Lung-EPCAM-24m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSPOAP1 CNTN5 SAMSN1 BHLHE40	1.36e-04	179	65	4	51872338e54c5f3e42ca9f1c4cf1e8b0cb84afcc
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B EPB41L3 AGAP3	1.36e-04	179	65	4	6624a2e731ab2d6c2eec19445e3dc509f581a8a9
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17\|GI_large-bowel / Manually curated celltypes from each tissue	LAT HLA-A LZTS1 BHLHE40	1.36e-04	179	65	4	6359f30005b17dc5b5c4c8f3a6a38c87ccfe4ee9
ToppCell	facs-Lung-EPCAM-24m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSPOAP1 CNTN5 SAMSN1 BHLHE40	1.36e-04	179	65	4	1b979e0203a2ddfe98bf6c2c80c4af1ba437a80f
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PSD3 ADARB1 AGAP2 AGAP3	1.39e-04	180	65	4	a682a5d55c612709c9ee9fa4289d6f8bef7fe1af
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAT HLA-A TIAM1 SAMSN1	1.42e-04	181	65	4	a6c8b33a392de3df2f179317e329e45d3d8c6f52
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-A HLA-B CNTN5 NCKAP5	1.42e-04	181	65	4	2f3d04d22d4ac016e61709ea5af3d48885c946c4
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-B CNTN5 HPSE2 NCKAP5	1.48e-04	183	65	4	5e361be3ae3fe05098968e58427630127bd12675
ToppCell	Frontal_cortex-Neuronal-Excitatory\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MYCBP2 LZTS1 PSD3 KCNH3	1.51e-04	184	65	4	6e17c8151d6dc543de16d804db956c63c3fda414
ToppCell	COVID-19_Severe-gd_T\|COVID-19_Severe / Disease condition and Cell class	HLA-A HLA-B TSPOAP1 BHLHE40	1.51e-04	184	65	4	791f1bcb954aadc63d4117c400537d036f68734d
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-A HLA-B CNTN5 NCKAP5	1.54e-04	185	65	4	487fa382232564f075960899d50afa0edae5d258
ToppCell	droplet-Thymus\|droplet / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NHSL1 LAT CNN3 KCNH3	1.54e-04	185	65	4	83a78d17ad59503a694c1250082c4d8ae74d63e1
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTX2 TIAM1 PSD3 ADARB1	1.54e-04	185	65	4	cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN1_thymic_pro-T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-A HLA-B SAMSN1 BHLHE40	1.54e-04	185	65	4	5db31631a4b4c4bfeb28f02d8dab00a48d77bcba
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Treg\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAT HLA-A HLA-B SAMSN1	1.57e-04	186	65	4	2a9daf96c2a47f1ed5421130f32f17bd33e644a7
ToppCell	COVID-19_Severe-CD4+_CTL\|COVID-19_Severe / Disease condition and Cell class	HLA-A HLA-B SAMSN1 BHLHE40	1.57e-04	186	65	4	728d81405fdcd137097433dd676b26519185e916
ToppCell	metastatic_Brain-T/NK_cells-Treg\|metastatic_Brain / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.60e-04	187	65	4	1b88e1399809c50a0156096d9c82b1d9e58bb720
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-A HLA-B CNTN5 NCKAP5	1.60e-04	187	65	4	02105c82a9ba79d2f19e002188377fc3440770c2
ToppCell	390C-Lymphocytic-CD4_T-cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	LAT HLA-A HLA-B SAMSN1	1.64e-04	188	65	4	0da6d6d3c28e9d99159b1a24a345a2250e8e1995
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAT HLA-A HLA-B SAMSN1	1.67e-04	189	65	4	5c92516c3745ccbd480b15bb2b9077ab1d9ee5a0
ToppCell	tumor_Lung-MAST_cells-MAST\|tumor_Lung / Location, Cell class and cell subclass	LAT SAMSN1 PBX1 BHLHE40	1.67e-04	189	65	4	cd977962e01756b663728dae32ab9aba15bf7e22
ToppCell	tumor_Lung-MAST_cells\|tumor_Lung / Location, Cell class and cell subclass	LAT SAMSN1 PBX1 BHLHE40	1.67e-04	189	65	4	300670be76454f197bd04f82c533579dd3671969
ToppCell	Hippocampus-Neuronal-Excitatory\|Hippocampus / BrainAtlas - Mouse McCarroll V32	LZTS1 PSD3 KCNH3 AGAP2	1.67e-04	189	65	4	4b90d181eb0a42814eeb23bc82e52fd3a12392a7
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-Th17\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LAT HLA-A HLA-B AGAP2	1.71e-04	190	65	4	3dcdd243aace89a8d080e9e181dffd2c56e770f0
ToppCell	metastatic_Lymph_Node-T/NK_cells-Treg\|metastatic_Lymph_Node / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.71e-04	190	65	4	0523f1039b39a45a23f2f4444e5b47ed581fc4bb
ToppCell	metastatic_Lymph_Node-T/NK_cells-Exhausted_CD8+_T\|metastatic_Lymph_Node / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.71e-04	190	65	4	cb4cf8ae2156c20b7978ae2e55aa605b4e90f455
ToppCell	metastatic_Brain-T/NK_cells-Exhausted_CD8+_T\|metastatic_Brain / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.74e-04	191	65	4	b98367fdb56ccb335d61035e69cd43c61a7fa816
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-Treg\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.78e-04	192	65	4	c550b49abd30234851e19f35ad5ab8aba44bd3b5
ToppCell	normal_Lymph_Node-T/NK_cells-Treg\|normal_Lymph_Node / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.78e-04	192	65	4	d2c2a98d331522a3ab7973bfaf4396ef4d684888
ToppCell	367C-Lymphocytic-CD4_T-cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	LAT HLA-A HLA-B SAMSN1	1.78e-04	192	65	4	7181174ea95abbeb6628d992b4fbae2f2af5edc6
ToppCell	ILEUM-non-inflamed-(1)_Th17_Trm\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HLA-A HLA-B SAMSN1 BHLHE40	1.78e-04	192	65	4	7347ff4dedd1aaa489c4f15e5ae647a4ce39ac72
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tregs\|lymph-node_spleen / Manually curated celltypes from each tissue	LAT HLA-A TIAM1 SAMSN1	1.78e-04	192	65	4	04bd6e135733570e877af9460f87379ed0a5c5f8
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Treg\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	LAT HLA-A HLA-B SAMSN1	1.78e-04	192	65	4	0deb6aa323e1de72ee8a2002449e523dd4f0bf5d
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	NCKAP5 EPB41L3 VPS13B CDKAL1	1.78e-04	192	65	4	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	ILEUM-inflamed-(1)_Th17_Trm\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HLA-A HLA-B SAMSN1 BHLHE40	1.81e-04	193	65	4	0663c57e1b8b8dd70d617d029fc7bdbbda8c1208
ToppCell	tumor_Lung-T/NK_cells-Treg\|tumor_Lung / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.81e-04	193	65	4	675645fb2e8e75fedba2ab51f67200961bfd2436
ToppCell	367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|367C / Donor, Lineage, Cell class and subclass (all cells)	LAT HLA-A HLA-B SAMSN1	1.81e-04	193	65	4	8f8d2006fb40a207c743cfd2e9a9f47c2bac1eea
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD4+_Th\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.81e-04	193	65	4	ebb22400b683a7d135448822ad2a32cb1059e104
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-NKT1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LAT HLA-A HLA-B AGAP2	1.81e-04	193	65	4	52f42ec293a5077a44de5c27e89b57c23944e560
ToppCell	metastatic_Lymph_Node-T/NK_cells-CD4+_Th\|metastatic_Lymph_Node / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.85e-04	194	65	4	1ce9b4c1fbdbc5e39c03adf7ffba3d0efea81862
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAT HLA-A HLA-B SAMSN1	1.85e-04	194	65	4	1bb5ac162f547de9dd91680df247b49a00920062
ToppCell	tumor_Lung-T/NK_cells-Exhausted_CD8+_T\|tumor_Lung / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.85e-04	194	65	4	3fdcfd04174e39491d4f1e6276acc9d11e5a4345
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAT HLA-A HLA-B SAMSN1	1.85e-04	194	65	4	2e614d86c366a022929ae307f170db8b142c386a
ToppCell	T/NK_cells-NKT_cell\|World / Lineage and Cell class	LAT HLA-A HLA-B BHLHE40	1.85e-04	194	65	4	8e09989ec2d1bbfe70cb18321c2ae94e0d0d9f18
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAT HLA-A HLA-B SAMSN1	1.85e-04	194	65	4	7937f2d1113bd85fee0df95fab74b0e022cdebce
ToppCell	3'-Pediatric_IBD\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAT HLA-A HLA-B SAMSN1	1.88e-04	195	65	4	728776511e1f40f127f80ef1eecda6d6ad082392
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LZTS1 TRO CNTN5 KCNH3	1.88e-04	195	65	4	ffbab350e67d9c4b66c0ab84550daec8b8139a27
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17\|lymph-node_spleen / Manually curated celltypes from each tissue	HLA-A HLA-B SAMSN1 BHLHE40	1.88e-04	195	65	4	c60982804a74dbe6607c021799ca74af2204aba8
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_CD8+_T\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.88e-04	195	65	4	f2029195d5b655120a9e84074b2583e2d89c0a1d
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 BOD1L1 EPB41L3 AFF4	1.88e-04	195	65	4	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	HLA-A HLA-B TSPOAP1 BHLHE40	1.88e-04	195	65	4	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	proximal-Hematologic-Basophil/Mast_1-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LAT SAMSN1 BHLHE40 HNRNPH2	1.92e-04	196	65	4	d3ca25df013967b9d871c01a4785a76661b784ca
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNN3 HNRNPH1 HNRNPH2 AFF4	1.92e-04	196	65	4	66d76249bd2770cdddff2c1fe59a016e95da2124
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B BOD1L1 SAMSN1	1.92e-04	196	65	4	fe8d3f45a64323947c36b127355d5940eb56c0ca
ToppCell	tumor_Lung-T/NK_cells\|tumor_Lung / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.92e-04	196	65	4	13396bb5f0dd0dce7219d3f7a1fc1fcb6b1ee134
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAT HLA-A HLA-B SAMSN1	1.92e-04	196	65	4	530ac678d2be035e9e943302d51288cb810b3972
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-A HLA-B TSPOAP1 BHLHE40	1.92e-04	196	65	4	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-A HLA-B TSPOAP1 BHLHE40	1.92e-04	196	65	4	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	proximal-3-Hematologic-Basophil/Mast_1\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LAT SAMSN1 BHLHE40 HNRNPH2	1.92e-04	196	65	4	1a5d0d2fee932f97614bf923686fdc2655c7ca75
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8\|bone_marrow / Manually curated celltypes from each tissue	LAT HLA-A HLA-B BHLHE40	1.92e-04	196	65	4	f23c33ad10f933250be98e8389a9aa278e876f96
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNN3 HNRNPH1 HNRNPH2 AFF4	1.92e-04	196	65	4	9bd4c146fc7555e32adfa393b3a07846eb826d25
ToppCell	moderate-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LAT HLA-A HLA-B HNRNPH1	1.92e-04	196	65	4	9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-A HLA-B TSPOAP1 BHLHE40	1.92e-04	196	65	4	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-A HLA-B TSPOAP1 BHLHE40	1.92e-04	196	65	4	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-A HLA-B BOD1L1 SAMSN1	1.92e-04	196	65	4	526d037bb12d81f1c235c60ddc787fbad0bbad77
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAJA2 HNRNPH1 HNRNPH2 AFF4	1.92e-04	196	65	4	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	proximal-Hematologic-Basophil/Mast_1\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LAT SAMSN1 BHLHE40 HNRNPH2	1.92e-04	196	65	4	9dddf3f33d8f507313f24dfb34d68bcafa064e94
ToppCell	tumor_Lung-T/NK_cells-CD4+_Th\|tumor_Lung / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.92e-04	196	65	4	42f6441505b6f04321da7953d7fe28088b8bdb89
ToppCell	cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LAT HLA-A HLA-B SAMSN1	1.96e-04	197	65	4	b6ad0a310f557b97d8192a2389692bf3567800cc
ToppCell	facs-Trachea-3m\|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BHLHE40 CNN3 HNRNPH1 AFF4	1.96e-04	197	65	4	e77016d64b1cac9825fec7cfe5071f1567401187
ToppCell	tumor_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th\|tumor_Lung / Location, Cell class and cell subclass	LAT HLA-A HLA-B SAMSN1	1.96e-04	197	65	4	de26ca046038e34790cece24529a05d491e6f8ef
ToppCell	facs-Trachea-nan-3m\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BHLHE40 CNN3 HNRNPH1 AFF4	1.96e-04	197	65	4	0353d925ee4b7aefc2c51b5fab873f465cdf9ebc
ToppCell	18-Airway-Immune\|Airway / Age, Tissue, Lineage and Cell class	LAT HLA-A HLA-B SAMSN1	1.96e-04	197	65	4	b28dd2aecb0658fbf48db06b675ed466d08d04eb
ToppCell	healthy_donor-Lymphocytic-ILC-NK_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	HLA-A HLA-B TSPOAP1 BHLHE40	2.00e-04	198	65	4	d7053a898e04478c577381085f615edaad3cdc5b
Drug	Anabasine [494-52-0]; Down 200; 24.6uM; MCF7; HT_HG-U133A	KRT24 TIAM1 DOK4 ZNF480 PCDHA6 ADARB1 BHLHE40 CDKAL1	9.75e-08	199	65	8	6074_DN
Drug	Nizatidine [76963-41-2]; Down 200; 12uM; HL60; HT_HG-U133A	LAT PSD3 ZNF480 MYO15A AFF4 CDKAL1 WDTC1	1.39e-06	195	65	7	3047_DN
Drug	Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; HL60; HT_HG-U133A	EPOR TSPOAP1 DSPP P3H1 AGA ZNF480 CDKAL1	1.44e-06	196	65	7	2339_DN
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A	EPOR DOK4 PSD3 ZNF480 HNRNPH1 CDKAL1 WDTC1	1.49e-06	197	65	7	5238_DN
Drug	Rifampicin [13292-46-1]; Up 200; 4.8uM; HL60; HT_HG-U133A	KRT24 CNTN5 PBX1 ADARB1 AFF4 CDKAL1 AGAP2	1.54e-06	198	65	7	2487_UP
Drug	Isradipine [75695-93-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A	KRT24 LAT DOK4 BHLHE40 VPS13B AGAP2 WDTC1	1.54e-06	198	65	7	6508_UP
Drug	azulenoid	OTX2 LAT HLA-A HLA-B	1.48e-05	52	65	4	CID000239540
Drug	Carcinine [56897-53-1]; Down 200; 22uM; PC3; HT_HG-U133A	EPOR TIAM1 DSPP PEX1 MYO15A CDKAL1	1.87e-05	193	65	6	4225_DN
Drug	Solanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A	EPOR PSD3 PEX1 ZNF480 HNRNPH1 CDKAL1	1.98e-05	195	65	6	2808_DN
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A	GIT1 PSD3 PCDHA6 ADARB1 CDKAL1 AGAP2	1.98e-05	195	65	6	4373_DN
Drug	Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A	EPOR TIAM1 MYO15A BHLHE40 STAT5B WDTC1	1.98e-05	195	65	6	7468_UP
Drug	Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A	EPOR TIAM1 GIT1 PCDHA6 ADARB1 AFF4	2.04e-05	196	65	6	3217_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	DOK4 DSPP PSD3 AFF4 LRCH3 WDTC1	2.10e-05	197	65	6	5605_DN
Drug	Trolox [53188-07-1]; Up 200; 16uM; MCF7; HT_HG-U133A	EPOR DOK4 PSD3 VPS13B CDKAL1 WDTC1	2.22e-05	199	65	6	6007_UP
Drug	Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A	DOK4 MYO15A EPB41L3 ADARB1 VPS13B CDKAL1	2.22e-05	199	65	6	5994_UP
Drug	beta- Belladonnine dichloroethylate [191355-47-2]; Up 200; 6uM; MCF7; HT_HG-U133A	LAT DOK4 DSPP PSD3 ADARB1 AGAP2	2.22e-05	199	65	6	4984_UP
Drug	Gly-L-Ser	EPOR HLA-B CNTN5	2.45e-05	20	65	3	CID000073086
Drug	PMSD	HLA-A HLA-B	7.98e-05	5	65	2	CID000083890
Drug	brinzolamide	HLA-A HLA-B	7.98e-05	5	65	2	ctd:C111827
Drug	Pimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	CNTN5 ADARB1 BHLHE40 VPS13B AGAP2	1.13e-04	166	65	5	6780_UP
Drug	Alexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A	TRO HPSE2 BHLHE40 HNRNPH1 AGAP2	1.60e-04	179	65	5	4721_UP
Drug	Al per	HLA-A HLA-B AGAP2	1.89e-04	39	65	3	CID009576740
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	ZXDC EPOR DOK4 PCDHA6 BHLHE40	1.91e-04	186	65	5	6996_UP
Drug	Chrysene-1,4-quinone [100900-16-1]; Up 200; 15.4uM; HL60; HG-U133A	LZTS1 RBM14 PBX1 EPB41L3 WDTC1	2.17e-04	191	65	5	1773_UP
Drug	Prednisolone [50-24-8]; Up 200; 11uM; HL60; HT_HG-U133A	LAT PEX1 SAMSN1 PBX1 WDTC1	2.17e-04	191	65	5	2393_UP
Drug	Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	EPOR GIT1 ZNF480 VPS13B WDTC1	2.22e-04	192	65	5	2873_DN
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A	EPOR PSD3 ZNF480 VPS13B AGAP2	2.22e-04	192	65	5	3400_DN
Drug	Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A	GIT1 PSD3 PBX1 CDKAL1 WDTC1	2.27e-04	193	65	5	2093_UP
Drug	Glycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A	DOK4 PCDHA6 SAMSN1 MYO15A BHLHE40	2.33e-04	194	65	5	4709_UP
Drug	Sulfaquinoxaline sodium salt [967-80-6]; Down 200; 12.4uM; MCF7; HT_HG-U133A	KRT24 DOK4 ADARB1 BHLHE40 WDTC1	2.33e-04	194	65	5	6090_DN
Drug	Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	KRT24 LAT CNTN5 PBX1 AFF4	2.33e-04	194	65	5	4082_UP
Drug	Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A	KRT24 DOK4 HPSE2 VPS13B AFF4	2.38e-04	195	65	5	2317_UP
Drug	Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A	EPOR ZNF480 PBX1 CDKAL1 WDTC1	2.38e-04	195	65	5	5093_DN
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A	DSPP ADARB1 AFF4 CDKAL1 WDTC1	2.38e-04	195	65	5	2240_DN
Drug	Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; PC3; HT_HG-U133A	EPOR LAT GIT1 DSPP ZNF480	2.38e-04	195	65	5	5763_DN
Drug	Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A	KRT24 LAT ADARB1 CDKAL1 WDTC1	2.38e-04	195	65	5	3321_UP
Drug	Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A	DOK4 HPSE2 SAMSN1 ADARB1 BHLHE40	2.38e-04	195	65	5	5401_UP
Drug	Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A	EPOR GIT1 PSD3 ZNF480 CDKAL1	2.38e-04	195	65	5	5269_DN
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	EPOR MAN2B1 P3H1 PCDHA6 STAT5B	2.44e-04	196	65	5	7022_DN
Drug	Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A	DOK4 PSD3 ZNF480 AFF4 CDKAL1	2.44e-04	196	65	5	5446_DN
Drug	Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A	TIAM1 VPS13B HNRNPH1 CDKAL1 WDTC1	2.44e-04	196	65	5	2888_DN
Drug	Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A	LAT PCDHA6 HNRNPH1 CDKAL1 WDTC1	2.44e-04	196	65	5	4720_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA	DSPP UBR4 ADARB1 BHLHE40 WDTC1	2.50e-04	197	65	5	1003_UP
Drug	Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; MCF7; HT_HG-U133A	EPOR LAT TSPOAP1 CDKAL1 STAT5B	2.50e-04	197	65	5	3233_UP
Drug	Indomethacin [53-86-1]; Up 200; 11.2uM; PC3; HT_HG-U133A	KRT24 CNTN5 HPSE2 MYO15A STAT5B	2.50e-04	197	65	5	5049_UP
Drug	Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A	EPOR GIT1 VPS13B CDKAL1 STAT5B	2.50e-04	197	65	5	2868_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	EPOR DOK4 GIT1 CDKAL1 WDTC1	2.50e-04	197	65	5	3885_DN
Drug	Amphotericin B [1397-89-3]; Up 200; 4.4uM; MCF7; HT_HG-U133A	KRT24 LAT ZNF480 PCDHA6 WDTC1	2.50e-04	197	65	5	3303_UP
Drug	Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	KRT24 DOK4 PEX1 CDKAL1 WDTC1	2.50e-04	197	65	5	7350_DN
Drug	Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; HL60; HT_HG-U133A	LAT UBR4 PSD3 ADARB1 CDKAL1	2.50e-04	197	65	5	2380_UP
Drug	Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A	DSPP TRO MYO15A CDKAL1 WDTC1	2.50e-04	197	65	5	7283_UP
Drug	Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PSD3 VPS13B HNRNPH1 CDKAL1 WDTC1	2.56e-04	198	65	5	6800_UP
Drug	Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; MCF7; HT_HG-U133A	EPOR DOK4 P3H1 PSD3 CDKAL1	2.56e-04	198	65	5	5383_DN
Drug	Nabumetone [42924-53-8]; Up 200; 17.6uM; MCF7; HT_HG-U133A	EPOR PSD3 HPSE2 MYO15A CDKAL1	2.56e-04	198	65	5	6487_UP
Drug	Rolipram [61413-54-5]; Down 200; 14.6uM; PC3; HT_HG-U133A	EPOR TIAM1 SAMSN1 PBX1 CDKAL1	2.56e-04	198	65	5	6730_DN
Drug	Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; PC3; HT_HG-U133A	TRO SAMSN1 BHLHE40 AFF4 WDTC1	2.56e-04	198	65	5	5870_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	PEX1 ZNF480 HNRNPH1 CDKAL1 WDTC1	2.56e-04	198	65	5	4348_DN
Drug	Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; PC3; HT_HG-U133A	TIAM1 DSPP PSD3 MYO15A WDTC1	2.56e-04	198	65	5	4187_DN
Drug	Triflusal [322-79-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	EPOR KRT24 PCDHA6 HNRNPH1 STAT5B	2.56e-04	198	65	5	7451_UP
Drug	Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	EPOR KRT24 LAT PCDHA6 AGAP2	2.56e-04	198	65	5	4782_UP
Drug	Corticosterone [50-22-6]; Up 200; 11.6uM; PC3; HT_HG-U133A	KRT24 CNTN5 ZNF480 PBX1 AGAP2	2.56e-04	198	65	5	4064_UP
Drug	Butamben [94-25-7]; Down 200; 20.6uM; MCF7; HT_HG-U133A	TIAM1 DOK4 PEX1 ADARB1 CDKAL1	2.62e-04	199	65	5	6093_DN
Drug	Pheniramine maleate [132-20-7]; Down 200; 11.2uM; PC3; HT_HG-U133A	EPOR GIT1 PEX1 PBX1 WDTC1	2.62e-04	199	65	5	4012_DN
Drug	Sulfisoxazole [127-69-5]; Up 200; 15uM; HL60; HG-U133A	LAT IFT88 GIT1 TSPOAP1 WDTC1	2.62e-04	199	65	5	1603_UP
Drug	Levodopa [59-92-7]; Up 200; 20.2uM; PC3; HT_HG-U133A	TIAM1 DSPP HNRNPH1 AFF4 CDKAL1	2.62e-04	199	65	5	4571_UP
Drug	Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; PC3; HT_HG-U133A	KRT24 CNTN5 PBX1 AFF4 AGAP2	2.68e-04	200	65	5	4091_UP
Drug	procyanidin A2	HLA-A HLA-B	2.85e-04	9	65	2	CID000124025
Disease	–	HLA-A HLA-B	4.63e-06	2	64	2	608579
Disease	Susceptibility to severe cutaneous adverse reaction	HLA-A HLA-B	4.63e-06	2	64	2	cv:C1840548
Disease	Carbamazepine response	HLA-A HLA-B	4.63e-06	2	64	2	cv:CN077964
Disease	susceptibility to cold sores measurement	HLA-B LZTS1 MUC16 CDKAL1	1.23e-05	65	64	4	EFO_0008402
Disease	4-acetamidobutanoate-to-N1-methyladenosine ratio	NAT2 PSD3	1.39e-05	3	64	2	EFO_0021418
Disease	N-acetyl-cadaverine measurement	NAT2 PSD3	1.39e-05	3	64	2	EFO_0800045
Disease	X-12410 measurement	NAT2 PSD3	1.39e-05	3	64	2	EFO_0800715
Disease	Stevens-Johnson syndrome (is_implicated_in)	HLA-A HLA-B	2.77e-05	4	64	2	DOID:0050426 (is_implicated_in)
Disease	response to anti-tuberculosis drug, tuberculosis, drug-induced liver injury	NAT2 PSD3	2.77e-05	4	64	2	EFO_0004228, EFO_0007918, MONDO_0018076
Disease	ras-related protein Rab-26 measurement	HLA-A TSPOAP1	4.61e-05	5	64	2	EFO_0801989
Disease	brain disease (implicated_via_orthology)	TIAM1 MYCBP2	6.91e-05	6	64	2	DOID:936 (implicated_via_orthology)
Disease	childhood onset asthma	FLG HLA-A HLA-B HPSE2 HRNR STAT5B	8.68e-05	334	64	6	MONDO_0005405
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-A HLA-B	9.66e-05	7	64	2	DOID:0081267 (implicated_via_orthology)
Disease	asparagine measurement	AGA A2ML1 PHC1	9.78e-05	41	64	3	EFO_0009766
Disease	urinary bladder carcinoma	NAT2 PSD3 CDKAL1	1.47e-04	47	64	3	MONDO_0004986
Disease	advanced glycation end-product measurement	NAT2 PSD3	1.65e-04	9	64	2	EFO_0007819
Disease	5-acetylamino-6-formylamino-3-methyluracil measurement	NAT2 PSD3	1.65e-04	9	64	2	EFO_0800950
Disease	diabetes mellitus biomarker	LZTS1 CDKAL1	2.06e-04	10	64	2	EFO_0006842
Disease	beta-2 microglobulin measurement	HLA-A HLA-B	2.52e-04	11	64	2	EFO_0005197
Disease	1-methylxanthine measurement	NAT2 PSD3	2.52e-04	11	64	2	EFO_0021174
Disease	5-acetylamino-6-amino-3-methyluracil measurement	NAT2 PSD3	2.52e-04	11	64	2	EFO_0800951
Disease	N-acetylputrescine measurement	NAT2 PSD3	3.01e-04	12	64	2	EFO_0800127
Disease	N-acetylglutamine measurement	NAT2 PSD3	3.56e-04	13	64	2	EFO_0800017
Disease	1-methylurate measurement	NAT2 PSD3	4.14e-04	14	64	2	EFO_0021173
Disease	triglycerides in very small VLDL measurement	NAT2 HLA-B PSD3	4.41e-04	68	64	3	EFO_0022144
Disease	Malignant Glioma	HLA-A HLA-B PSD3	4.80e-04	70	64	3	C0555198
Disease	mixed gliomas	HLA-A HLA-B PSD3	4.80e-04	70	64	3	C0259783
Disease	4-acetamidobutanoate measurement	NAT2 PSD3	5.45e-04	16	64	2	EFO_0021003
Disease	Dermatitis	FLG HLA-B	5.45e-04	16	64	2	C0011603
Disease	methylcobalamin deficiency type cblE, brain serotonin transporter measurement	NAT2 PSD3	5.45e-04	16	64	2	EFO_0004569, MONDO_0009354
Disease	free cholesterol to total lipids in large LDL percentage	NAT2 HLA-B PSD3	5.65e-04	74	64	3	EFO_0022280
Disease	lymphocyte percentage of leukocytes	HLA-A HLA-B TSPOAP1 CNTN5 PCDHA6 HNRNPH1 STAT5B	5.84e-04	665	64	7	EFO_0007993
Disease	preeclampsia	OTX2 MYCBP2 LZTS1	6.59e-04	78	64	3	EFO_0000668
Disease	small cell lung carcinoma	HLA-B A2ML1 PHC1	7.10e-04	80	64	3	EFO_0000702
Disease	iron biomarker measurement, transferrin measurement	NAT2 PSD3	8.58e-04	20	64	2	EFO_0004461, EFO_0006341
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	NAT2 HLA-B PSD3	8.76e-04	86	64	3	EFO_0008595, EFO_0020945
Disease	Glioma	HLA-A HLA-B PSD3	9.06e-04	87	64	3	C0017638
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	NAT2 HLA-A HLA-B PSD3	9.47e-04	200	64	4	EFO_0004611, EFO_0020945
Disease	metabolic syndrome	NAT2 HLA-B PSD3 CDKAL1	9.47e-04	200	64	4	EFO_0000195
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	NAT2 HLA-B PSD3 STAT5B	1.06e-03	206	64	4	EFO_0004612, EFO_0020947
Disease	asthma	FLG KRT24 HLA-B TMEM132D TCHHL1 MUC16 STAT5B	1.19e-03	751	64	7	MONDO_0004979
Disease	chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement	NAT2 HLA-B PSD3	1.20e-03	96	64	3	EFO_0004530, EFO_0008317, EFO_0008596
Disease	blood tin measurement	NAT2 PSD3	1.35e-03	25	64	2	EFO_0021530
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	NAT2 HLA-A HLA-B PSD3	1.39e-03	222	64	4	EFO_0008317, EFO_0020943
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	NAT2 HLA-A HLA-B PSD3	1.46e-03	225	64	4	EFO_0008317, EFO_0010351
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	NAT2 HLA-A HLA-B PSD3	1.46e-03	225	64	4	EFO_0008317, EFO_0020947
Disease	glaucoma (biomarker_via_orthology)	EPOR PBX1	1.69e-03	28	64	2	DOID:1686 (biomarker_via_orthology)
Disease	tuberculosis (is_implicated_in)	HLA-A HLA-B	1.69e-03	28	64	2	DOID:399 (is_implicated_in)
Disease	hippocampus volume change measurement, age at assessment	A2ML1 PHC1	1.81e-03	29	64	2	EFO_0008007, EFO_0021492
Disease	Drug-Induced Stevens Johnson Syndrome	HLA-A HLA-B	1.81e-03	29	64	2	C1274933
Disease	1,5 anhydroglucitol measurement	PCDHA6 NCKAP5	1.81e-03	29	64	2	EFO_0008009
Disease	Toxic Epidermal Necrolysis	HLA-A HLA-B	1.81e-03	29	64	2	C0014518
Disease	diabetes mellitus (is_implicated_in)	NAT2 CDKAL1	1.81e-03	29	64	2	DOID:9351 (is_implicated_in)
Disease	Mycoplasma-Induced Stevens-Johnson Syndrome	HLA-A HLA-B	1.81e-03	29	64	2	C3658301
Disease	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	HLA-A HLA-B	1.81e-03	29	64	2	C3658302
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	NAT2 HLA-A HLA-B PSD3	1.82e-03	239	64	4	EFO_0008317, EFO_0020945
Disease	Stevens-Johnson Syndrome	HLA-A HLA-B	1.94e-03	30	64	2	C0038325
Disease	lymphocyte measurement	HLA-A HLA-B LZTS1	2.12e-03	117	64	3	EFO_0803546

Protein segments in the cluster

Peptide	Gene	Start	Entry
NQATNGGGSAFSDYS	AGAP3	286	Q96P47
SGEQSGSDTDTDSGY	BHLHE40	231	O14503
GSYSAFGERDGNGNT	A2ML1	1021	A8K2U0
AGQASNGGHTSDYSS	AGAP2	596	Q99490
VGHSNTGSDSNSDGY	DSPP	436	Q9NZW4
GSGADSDYENTQSGD	GIT1	591	Q9Y2X7
AGQYASVFVDNGSGA	C1QTNF12	271	Q5T7M4
DSGHRGYSGSQASDN	FLG	2681	P20930
GYSGSQASDNEGHSE	FLG	2686	P20930
SGHRGYSGSQASDNE	FLG	3006	P20930
GREQGTGNSYTDTSG	AFF4	506	Q9UHB7
RAYSEGGDGTASSQI	CNTN5	1046	O94779
QAAAASSLNSYGAQG	RBM14	321	Q96PK6
NTQGAASSLGSYGAQ	RBM14	366	Q96PK6
YSADQGDSSEGGTLA	QSOX2	571	Q6ZRP7
DAAGTSNGVRVTGYA	TSPOAP1	1006	O95153
NVAATSGDGYRGQTS	P3H1	491	Q32P28
ASDRDEGANGAISYS	PCDHA6	266	Q9UN73
SYNLGAGGGSAEVDT	KCNH3	701	Q9ULD8
SSNTYSLDGGSNVGG	MUC16	2431	Q8WXI7
SGGAGSDNSVEHSDY	PBX1	136	P40424
SRESGEEYESGSGSN	FLG2	216	Q5D862
TGSGQSSGFGQYESR	FLG2	1056	Q5D862
ISDSGQSTGFGQYGS	FLG2	1196	Q5D862
AAAEYSGTVASGGNL	LRCH3	11	Q96II8
DYTALSSGDLGGQAG	LZTS1	81	Q9Y250
DSDGYSSHNQDGTNG	MYO15A	2346	Q9UKN7
SDGANSVASYENEGA	LAT	101	O43561
ASGTGQDDADGHSVY	NHSL1	226	Q5SYE7
LNSTAGASGGAYGSQ	HNRNPH2	381	P55795
SGSSQSSRYGQQGSG	HRNR	641	Q86YZ3
SSFAEFGGRNSGSVN	KRT24	456	Q2M2I5
LNSTAGASGGAYGSQ	HNRNPH1	381	P31943
SAGGTNNLSDSYAAG	HPSE2	386	Q8WWQ2
YVGSNGDDSFSSSGD	ADARB1	191	P78563
GGSYSQAACSDSAQG	HLA-B	341	P01889
TASYSAGRGLEGNAN	BOD1L1	2486	Q8NFC6
GSGGGQRREAYNDSS	DNAJA2	381	O60884
REGSASGDSGQNYSA	IFT88	741	Q13099
SGDSGQNYSASSKGE	IFT88	746	Q13099
TSEDTGAYGRDIGTN	CDKAL1	256	Q5VV42
GGSYTQAASSDSAQG	HLA-A	341	P04439
ASIGDNESDQASGAY	MAN2B1	646	O00754
GRNYIVDAGSGSSSQ	NAT2	116	P11245
YADDTAGAAAATGNG	AGA	246	P20933
DSGISTDYSSGDSQG	EPOR	461	P19235
TDYSSGDSQGAQGGL	EPOR	466	P19235
DSDYGQTNGLSTIGA	DNAAF6	46	Q9NQM4
GSSYESELGNGTSSD	PEX1	1131	O43933
ASGDASYSAGDSGDA	EPB41L3	866	Q9Y2J2
GSQNIAEASSYAGEG	DOK4	276	Q8TEW6
QGYGASSLGFNSTTD	OTX2	241	P32243
AAGSENSADGASYEV	TMEM132D	366	Q14C87
ASGGSNSDSDLDYGD	NCKAP5	1871	O14513
RDSGCYISSGNSDNG	SAMSN1	336	Q9NSI8
FVNASADAGGGSATY	STAT5B	711	P51692
YTAALNDRDQGGGSA	MYCBP2	81	O75592
FAGSQGDYGDLQASS	SOX8	376	P57073
DYSGVGSSDGNSEES	ABHD10	111	Q9NUJ1
QGTGTNGSEISDSDY	CNN3	286	Q15417
GDEDSRGSADYNSLS	SLC7A6OS	261	Q96CW6
FGSNAQYIVSGSDDG	WDTC1	546	Q8N5D0
SAGTGNFYLESGGSA	ZXDC	701	Q2QGD7
GSSSTGDAARQGVYE	TIAM1	371	Q13009
SVSFGSALNTNAGYG	TRO	1016	Q12816
NAGYGGAVSTNTDFG	TRO	1026	Q12816
RGQEDSSRGSDNSSY	PHC1	876	P78364
GVNTGSSYALGSNAE	ZNF480	106	Q8WV37
SRYSGAQDSGIGSDS	VPS13B	1786	Q7Z7G8
GSETQYLSSEGGDQT	TCHHL1	441	Q5QJ38
VSGRSSAYGDATAEG	UBR4	2911	Q5T4S7
GSGDSSSYDAPAGNS	UPRT	81	Q96BW1
GYSSGVTNGLNDASD	PSD3	516	Q9NYI0